• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于肝细胞癌当前诊断与预后的考量

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.

作者信息

Cristea C G, Gheonea I A, Săndulescu L D, Gheonea D I, Ciurea T, Purcarea M R

机构信息

Department of Gastroenterology, Craiova University of Medicine and Pharmacy, Romania.

Department of Radiology, Craiova University of Medicine and Pharmacy, Romania.

出版信息

J Med Life. 2015 Apr-Jun;8(2):120-8.

PMID:25866565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4392085/
Abstract

Hepatocellular carcinoma is a major health issue, ranked the fifth most common tumor and currently being responsible for a third of the cancer-related deaths globally, with an ever-increasing number of fatalities. Current advances in contrast-enhanced imaging techniques such as contrast-enhanced ultrasonography, multi-detector computed tomography and diffusion-weighted magnetic resonance imaging are improving the rate of hepatocellular carcinoma diagnosis. Contrast-enhanced ultrasonography has widely become the first choice in liver tumor assessment, as it is faster, simpler and safer than other forms of diagnostic imaging. On the other hand, cross sectional computed tomography is frequently employed when a hepatic formation is suspected of malignancy and allows a more accurate characterization of lesions through multiphasic multi-detector computed tomography technology. Diffusion weighted magnetic resonance imaging represents another addition to the wide range of diagnostic and prognostic techniques available for patients with hepatocellular carcinoma and is currently regarded as one of the best tools for the characterization of these lesions. Furthermore, groundbreaking biomarkers for hepatocellular carcinoma are being discovered, although alpha-fetoprotein remains one of the most frequently used serum test in the early stages. Nonetheless, further advances are required for the detection of small liver carcinomas.

摘要

肝细胞癌是一个重大的健康问题,是全球第五大常见肿瘤,目前占全球癌症相关死亡人数的三分之一,且死亡人数不断增加。目前,超声造影、多排螺旋计算机断层扫描和扩散加权磁共振成像等对比增强成像技术的进展提高了肝细胞癌的诊断率。超声造影已广泛成为肝脏肿瘤评估的首选方法,因为它比其他形式的诊断成像更快、更简单、更安全。另一方面,当怀疑肝脏肿物为恶性时,经常采用横断面计算机断层扫描,通过多排螺旋计算机断层扫描技术可以更准确地对病变进行特征描述。扩散加权磁共振成像为肝细胞癌患者提供了广泛的诊断和预后技术,目前被认为是对这些病变进行特征描述的最佳工具之一。此外,尽管甲胎蛋白仍然是早期最常用的血清检测指标之一,但仍在发现肝细胞癌的突破性生物标志物。尽管如此,对于小肝癌的检测仍需要进一步的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/d16136faf1d8/JMedLife-08-120-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/2fdd683a8cc7/JMedLife-08-120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/ddac9ea21a7a/JMedLife-08-120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/dd4abecb7a23/JMedLife-08-120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/207a4ab5acae/JMedLife-08-120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/33e772270c77/JMedLife-08-120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/3e2875370607/JMedLife-08-120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/c33da63e51c2/JMedLife-08-120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/d16136faf1d8/JMedLife-08-120-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/2fdd683a8cc7/JMedLife-08-120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/ddac9ea21a7a/JMedLife-08-120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/dd4abecb7a23/JMedLife-08-120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/207a4ab5acae/JMedLife-08-120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/33e772270c77/JMedLife-08-120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/3e2875370607/JMedLife-08-120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/c33da63e51c2/JMedLife-08-120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd61/4392085/d16136faf1d8/JMedLife-08-120-g008.jpg

相似文献

1
Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.关于肝细胞癌当前诊断与预后的考量
J Med Life. 2015 Apr-Jun;8(2):120-8.
2
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.检测和描述肝脏局灶性病变:一项日本 III 期、多中心的钆塞酸二钠增强磁共振成像与增强计算机断层扫描对比研究,主要针对肝细胞癌和慢性肝病患者。
Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.
3
Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography.动脉门静脉造影术中计算机断层扫描无法检测到的小肝细胞结节发生肝细胞癌的概率。
Hepatology. 2000 Apr;31(4):890-8. doi: 10.1053/he.2000.5979.
4
Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.肝细胞癌的无创性影像学诊断与预后评估。
World J Gastroenterol. 2018 Jun 14;24(22):2348-2362. doi: 10.3748/wjg.v24.i22.2348.
5
Imaging of hepatocellular carcinoma: current concepts.肝细胞癌的影像学:当前概念
Recent Results Cancer Res. 2013;190:33-55. doi: 10.1007/978-3-642-16037-0_3.
6
Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.肝细胞癌不可逆电穿孔:磁共振成像、计算机断层扫描及超声造影在评估消融区域诊断准确性的初步报告
Radiol Med. 2016 Feb;121(2):122-31. doi: 10.1007/s11547-015-0582-5. Epub 2015 Sep 7.
7
Hepatocellular carcinoma: Advances in diagnostic imaging.肝细胞癌:诊断成像的进展
Drug Discov Ther. 2015 Oct;9(5):310-8. doi: 10.5582/ddt.2015.01058.
8
[Imaging diagnosis of hepatocellular carcinomas].
Gan To Kagaku Ryoho. 1989 Jan;16(1):25-33.
9
[Hepatocellular carcinoma in cirrhosis: semeiology and performance of magnetic resonance imaging and lipiodol computed tomography].[肝硬化中的肝细胞癌:磁共振成像和碘油计算机断层扫描的症状学及表现]
Gastroenterol Clin Biol. 1999 Jan;23(1):114-21.
10
Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.肝细胞癌的超声、计算机断层扫描和磁共振成像:走向更好的治疗决策。
Oncology. 2011;81 Suppl 1:86-99. doi: 10.1159/000333267. Epub 2011 Dec 22.

引用本文的文献

1
Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.m6A 和铁死亡相关 lncRNA 特征鉴定用于预测肝细胞癌的免疫疗效。
Front Immunol. 2022 Aug 11;13:914977. doi: 10.3389/fimmu.2022.914977. eCollection 2022.
2
OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma.OSlihc:一种用于肝细胞癌的在线预后生物标志物分析工具。
Front Pharmacol. 2020 Jun 10;11:875. doi: 10.3389/fphar.2020.00875. eCollection 2020.
3
High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma.

本文引用的文献

1
Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.对比增强超声(CEUS)用于评估肝脏局灶性病变——一项关于其在临床实践中实用性的前瞻性多中心研究。
Ultraschall Med. 2014 Jun;35(3):259-66. doi: 10.1055/s-0033-1355728. Epub 2014 Feb 21.
2
Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.血清GP73在肝细胞癌诊断中对甲胎蛋白(AFP)和γ-谷氨酰转移酶同工酶II(GGT-II)起到补充作用。
Oncol Lett. 2013 Oct;6(4):1152-1158. doi: 10.3892/ol.2013.1522. Epub 2013 Aug 9.
3
Diagnostic accuracy measures.
高KIAA1522表达预示肝细胞癌患者预后不良。
Oncol Lett. 2020 Jul;20(1):509-516. doi: 10.3892/ol.2020.11588. Epub 2020 May 6.
4
Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease.非膜结合型核磷酸肌醇结合蛋白在人类健康与疾病中的信号转导作用
J Lipid Res. 2019 Feb;60(2):299-311. doi: 10.1194/jlr.R088518. Epub 2018 Sep 10.
5
G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes.通过对关键通路和基因的分析,G2/M 检查点在肝癌早期发挥着至关重要的作用。
Oncotarget. 2017 Jul 18;8(44):76305-76317. doi: 10.18632/oncotarget.19351. eCollection 2017 Sep 29.
6
MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker.微小RNA-7通过靶向KLF-4抑制肝癌进展,并有望成为一种新型诊断生物标志物。
Cancer Cell Int. 2017 Feb 21;17:31. doi: 10.1186/s12935-017-0386-x. eCollection 2017.
7
MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.微小RNA-485-5p通过靶向2型鲟钙蛋白抑制肝细胞癌的细胞增殖和侵袭。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12292-9. eCollection 2015.
诊断准确性测量。
Cerebrovasc Dis. 2013;36(4):267-72. doi: 10.1159/000353863. Epub 2013 Oct 16.
4
Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma.在PET检查中向18F-FDG添加11C-乙酸盐对肝细胞癌的诊断具有增量价值。
Mol Imaging Radionucl Ther. 2012 Apr;21(1):6-12. doi: 10.4274/Mirt.87. Epub 2012 Apr 1.
5
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.甲胎蛋白异质体 3 和异常凝血酶原在总甲胎蛋白指导下对肝细胞癌的诊断价值。
World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339.
6
Des-gamma-carboxyprothrombin for early identification and prognosis of hepatocellular carcinoma--a case control study from western Nepal.去γ-羧基凝血酶原用于肝细胞癌的早期诊断及预后评估——来自尼泊尔西部的一项病例对照研究
Asian Pac J Cancer Prev. 2012;13(11):5773-5. doi: 10.7314/apjcp.2012.13.11.5773.
7
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.肝脏对比增强超声(CEUS)指南和临床实践良好建议-2012 年更新:WFUMB-EFSUMB 与 AFSUMB、AIUM、ASUM、FLAUS 和 ICUS 的代表合作开展的一项倡议。
Ultrasound Med Biol. 2013 Feb;39(2):187-210. doi: 10.1016/j.ultrasmedbio.2012.09.002. Epub 2012 Nov 5.
8
GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.GP73表达及其在肝细胞癌诊断中的意义:综述
Int J Clin Exp Pathol. 2012;5(9):874-81. Epub 2012 Oct 20.
9
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.近十年间肝细胞癌诊断指南的变化。
Clin Mol Hepatol. 2012 Sep;18(3):258-67. doi: 10.3350/cmh.2012.18.3.258. Epub 2012 Sep 25.
10
Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation.多期多排 CT 肝细胞癌的强化模式:与病理分化的比较。
Br J Radiol. 2012 Sep;85(1017):e573-83. doi: 10.1259/bjr/86767895.